Drug pricing

News

The UK is losing out to competitors in attracting investment in R&D, clinical trials, and capital projects, says a report from the ABPI pharma group.

News

In a blow to UK life science ambitions, MSD has scrapped a £1bn expansion of its operations in the country, saying it does not value innovation.

News

Lilly has paused shipments of weight loss therapy Mounjaro to the UK to prevent stockpiling ahead of a price rise, but patients report shortages.

News

EVERSANA has acquired Waltz Health, a Chicago digital health company offering AI-driven marketplaces to lower overall drug costs.

News

The UK government's threat to withdraw from negotiations on rebates paid by industry on NHS medicines has been followed by the collapse of talks.

News

Lilly has said it will raise the UK list price of its diabetes and obesity therapy Mounjaro to bring it into parity with other European markets.